Ii Robert C. Goeltz

CIK: 0001653881

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)7 (70.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (20.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (10.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

RCUS

Arcus Biosciences, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (10 total)

RCUS
Arcus Biosciences, Inc.
May 11, 2026
Sale(S)
Direct
7.8K shares at avg. $25.63$199K
RCUS
Arcus Biosciences, Inc.
Jan 23, 2026
Award(A)
Direct
24K shares-
RCUS
Arcus Biosciences, Inc.
Dec 31, 2025
Sale(S)
Direct
6.6K shares at avg. $23.38$153K
RCUS
Arcus Biosciences, Inc.
Dec 17, 2025
Sale(S)
Direct
6K shares at avg. $22.16$132K
RCUS
Arcus Biosciences, Inc.
Dec 16, 2025
Sale(S)
Direct
6.7K shares at avg. $21.88$147K
RCUS
Arcus Biosciences, Inc.
Nov 26, 2025
Sale(S)
Direct
5K shares at avg. $25.00$125K
RCUS
Arcus Biosciences, Inc.
Oct 28, 2025
Sale(S)
Direct
5K shares at avg. $20.00$100K
RCUS
Arcus Biosciences, Inc.
Jan 23, 2025
Award(A)
Direct
37K shares-
RCUS
Arcus Biosciences, Inc.
Dec 31, 2024
Sale(S)
Direct
3.6K shares at avg. $15.00$54K
RCUS
Arcus Biosciences, Inc.
Dec 15, 2024
Tax Payment(F)
Direct
10.1K shares at avg. $16.08$162K

		Type	Shares	Price		Ownership
May 11, 2026	RCUS Arcus Biosciences, Inc.	Sale(S)	7,763	$25.63	$198,966	Direct
Jan 23, 2026	RCUS Arcus Biosciences, Inc.	Award(A)	24,000	-	$0	Direct
Dec 31, 2025	RCUS Arcus Biosciences, Inc.	Sale(S)	6,552	$23.38	$153,186	Direct
Dec 17, 2025	RCUS Arcus Biosciences, Inc.	Sale(S)	5,960	$22.16	$132,071	Direct
Dec 16, 2025	RCUS Arcus Biosciences, Inc.	Sale(S)	6,702	$21.88	$146,669	Direct
Nov 26, 2025	RCUS Arcus Biosciences, Inc.	Sale(S)	5,000	$25.00	$125,000	Direct
Oct 28, 2025	RCUS Arcus Biosciences, Inc.	Sale(S)	5,000	$20.00	$100,000	Direct
Jan 23, 2025	RCUS Arcus Biosciences, Inc.	Award(A)	37,000	-	$0	Direct
Dec 31, 2024	RCUS Arcus Biosciences, Inc.	Sale(S)	3,594	$15.00	$53,910	Direct
Dec 15, 2024	RCUS Arcus Biosciences, Inc.	Tax Payment(F)	10,099	$16.08	$162,392	Direct

1-10 of 10 transactions

About Goeltz II Robert C.

Goeltz II Robert C. (SEC CIK 0001653881) files insider reports with the SEC as Chief Financial Officer of Arcus Biosciences, Inc. (RCUS).

Signal8 holds 9 ownership filings by Goeltz II Robert C., all Form 4s, filed between Dec 17, 2024 and May 12, 2026. Those filings report 10 transactions, from Dec 15, 2024 to May 11, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Goeltz II Robert C.'s filings is in HAYWARD, CA.

Recent filings by Goeltz II Robert C.

May 11, 2026: Open-market sale of RCUS shares (Form 4, code S).
Jan 23, 2026: Grant or award of RCUS shares (Form 4, code A).
Dec 31, 2025: Open-market sale of RCUS shares (Form 4, code S).
Dec 17, 2025: Open-market sale of RCUS shares (Form 4, code S).
Dec 16, 2025: Open-market sale of RCUS shares (Form 4, code S).

Other insiders filing for Arcus Biosciences, Inc. (RCUS)

Azoy Alexander, Chief Accounting Officer
Jaen Juan C., President
Lambert Nicole, Director
Machado Patrick, Director
KANEKO YASUNORI, Director
Tang Carolyn C., General Counsel

How to read Form 4 transaction codes